# Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System

> **NCT02663323** · NA · UNKNOWN · sponsor: **Meril Life Sciences Pvt. Ltd.** · enrollment: 64 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System

## Key facts

- **NCT ID:** NCT02663323
- **Lead sponsor:** Meril Life Sciences Pvt. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-02-02
- **Primary completion:** 2017-10-05
- **Final completion:** 2020-07-05
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2018-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02663323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02663323, "Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02663323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*